CheckMate 214 patients who discontinued first-line nivolumab + ipilimumab or sunitinib due to treatment-related adverse events Meeting Abstract
| Authors: | Grünwald, V.; Tannir, N. M.; Motzer, R. J.; Plimack, E. R.; McDermott, D. F.; Barthélémy, P.; Porta, C.; George, S.; Powles, T.; Donskov, F.; Kollmannsberger, C. K.; Gurney, H.; Amin, A.; Grimm, M. O.; Rini, B. I.; Tomita, Y.; McHenry, M. B.; Escudier, B.; Hammers, H. J. |
| Abstract Title: | CheckMate 214 patients who discontinued first-line nivolumab + ipilimumab or sunitinib due to treatment-related adverse events |
| Meeting Title: | Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 42 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Oct 11-14 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2019-10-01 |
| Start Page: | 150 |
| Language: | English |
| ACCESSION: | WOS:000568159600364 |
| PROVIDER: | wos |
| DOI: | 10.1159/000502425 |
| Notes: | "Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology" -- Meeting Abstract: V557 -- Source: Wos |
